News

Corbus Pharmaceuticals Completes Enrollment in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the completion of subject enrollment in DETERMINE, a Phase 3 study assessing the efficacy and safety of lenabasum for the treatment of dermatomyositis. Read more >>

Zylö and Grapefruit Forge Partnership That Promises to Disrupt the Topical Cannabis Market

Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that it has entered into an exclusive agreement with Grapefruit USA, Inc. to supply its Z-pod™ system as the technological underpinning of Grapefruit’s Hourglass™ time-release cannabinoid topical cream. Read more >>

The Top 100 Executives Of 2020

With the worldwide COVID-19 pandemic and social unrest wreaking havoc on the global economy, this year proved that never has leadership mattered more than now. And the CRN Top 100 IT Executives Of 2020 rose to the occasion time and time again — from providing financial relief to partners to making big bold technology bets aimed at driving an economic recovery to making charitable contributions and speaking out on social issues. List includes David Friend of Wasabi. Read more […]

New NAKIVO Backup & Replication v10 Features Linux Workstation Backup

NAKIVO Inc., a fast-growing software company dedicated to protecting virtual, physical, cloud and SaaS environments, announced today the release of NAKIVO Backup & Replication v10. NAKIVO Backup & Replication provides businesses with the tools they need to protect their entire IT infrastructure—from VMware, Hyper-V and Nutanix AHV VMs and Amazon EC2 instances to physical servers and workstations, Oracle databases, and Microsoft Office 365 application data. The introduction of Backup to Wasabi in v10 gives customers the power to leverage […]